Format

Send to

Choose Destination
Vaccine. 2019 Jan 3;37(1):76-79. doi: 10.1016/j.vaccine.2018.11.038. Epub 2018 Nov 23.

Similar relative risks of seizures following measles containing vaccination in children born preterm compared to full-term without previous seizures or seizure-related disorders.

Author information

1
Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute, Marshfield, WI, USA. Electronic address: mcclure.david@marshfieldclinic.org.
2
Kaiser Permanente Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.
3
Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland, CA, USA.
4
Kaiser Permanente Center for Health Research, Kaiser Permanente Northwest, Portland, OR, USA.
5
Health Partners Institute, Minneapolis, MN, USA.
6
Kaiser Permanente Institute for Health Research, Kaiser Permanente Colorado, Denver, CO, USA.
7
Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
8
Centers for Disease Control and Prevention, Immunization Safety Office, Atlanta, GA 30333, USA.
9
Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute, Marshfield, WI, USA.

Abstract

BACKGROUND:

Febrile seizures are associated with the first dose of measles-containing vaccines and the risk increases with chronologic age during the second year of life. We used the Vaccine Safety Datalink (VSD) to determine if the relative increase in risk of seizures following receipt of measles-containing vaccine differs by gestational age at birth.

METHODS:

Children were eligible if they received their first dose of measles-containing vaccine at age 12 through 23 months from January 2003 through September 2015. Children were excluded if they had a history of seizure or conditions strongly related to seizure prior to 12 months of age. Seizures were identified by diagnostic codes in the inpatient or emergency department settings. Using risk-interval analysis, we estimated the incidence rate ratio (IRR) for seizures in the 7 through 10 days (risk period) vs 15 through 42 days (control period) following receipt of measles-containing vaccines in children born preterm (<37 weeks gestation age) and those born full-term (≥37 weeks).

RESULTS:

There were 532,375 children (45,343 preterm and 487,032 full-term) who received their first dose of measles-containing vaccine at age 12 through 23 months. The IRRs of febrile seizures 7 through 10 days compared with 15 through 42 days after receipt of measles-containing vaccine were 3.9 (95% CI: 2.5-6.0) in preterm children and 3.2 (2.7-3.7) in full-term children; the ratio of IRRs: was 1.2 (0.76-1.9), p = 0.41. IRRs were also similar across gestational age groups, by vaccine type received (measles-mumps-rubella [MMR] or measles-mumps-rubella-varicella [MMRV]) and age at vaccination (12-15 or 16-23 months).

CONCLUSION:

Vaccination with a measles-containing vaccine in the second year of life is associated with a similar relative risk of a first seizure in children born preterm as in those who were born full-term.

KEYWORDS:

MMR; MMRV; Measles containing vaccine; Premature; Preterm; Seizures

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center